Log In
Print
BCIQ
Print
Print this Print this
 

GV2311

Also known as: RSV vaccine

  Manage Alerts
Collapse Summary General Information
Company GenVec Inc.
DescriptionHuman adenovirus vector vaccine against respiratory syncytial virus (RSV)
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector
Latest Stage of DevelopmentPreclinical
Standard IndicationRespiratory syncytial virus (RSV)
Indication DetailsPrevent respiratory syncytial virus (RSV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today